Mangumpit, Max Kaiden .

HRN: 21-94-28  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2023
CEFUROXIME 750MG (VIAL)
08/19/2023
08/26/2023
IVT
300mg
Q8
AGE
Waiting Final Action 
07/29/2025
CEFUROXIME 750MG (VIAL)
07/29/2025
08/05/2025
IV
440mg
Q8H
PCAP
Remove - Pending Acceptance
07/29/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
07/29/2025
08/05/2025
TOPICAL
1ml
QID
Oral Ulcers
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: